DJIA 17,067.56 -30.89 -0.18%
NASDAQ 4,598.19 17.92 0.39%
S&P 500 2,002.28 -1.09 -0.05%
market minute promo

Sanofi (ADR) (NYSE: SNY)



company name or ticker
Company Photos
(Click to zoom)

Properly Treating Costs: Re-Evaluating The MannKind And Sanofi Partnership

Blame MannKind's Fall on its Bloated Balance Sheet

Update: MannKind Q2 Earnings - Stock Sent To The Woodshed

What the Market is Telling MannKind

MannKind Posts Wider Q2 Loss, Up on Sanofi Deal for Afrezza - Analyst Blog

Why all the action is now in biotech

MannKind Corporation Stock Signs Up Sanofi, Investors Conflicted

MannKind establishes a partnership with Sanofi to market its inhaled insulin Afrezza.

MannKind Enters into a Global Deal with Sanofi for Afrezza - Analyst Blog

Synta Pharmaceuticals: The Data Justify A Much Higher Share Price

Closing Update: Stocks Firm, Pare Gains as NATO Questions Russian Aid Overtures to Revive Geopolitic

Closing Update: Stocks Firm, Pare Gains as NATO Questions Russian Aid Overtures to Revive Geopolitical Concern
See More Articles...